Stock Based Compensation - Schedule of Stock Options Activity (Details) - Stock options - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Number of options
Balance at beginning of period (in shares)	10,865,868
Granted (in shares)	0		4,914,868
Forfeited (in shares)	(64,499)
Exercised (in shares)	0	0	0
Balance at end of period (in shares)	10,801,369	10,865,868
Expected to vest at end of period (in shares)	4,721,369
Exercisable at end of period (in shares)	6,080,000
Weighted-average exercise price
Balance at beginning of period (USD per share)	$ 19.31
Granted (USD per share)	0
Forfeited (USD per share)	15.89
Exercised (USD per share)	0
Balance at end of period (USD per share)	19.33	$ 19.31
Expected to vest at end of period (USD per share)	15.89
Exercisable at end of period (USD per share)	$ 22.00
Weighted-average remaining contractual term (in years)	4 years 8 months 12 days	5 years 8 months 12 days
Weighted average remaining contractual term (in years) of options expected to vest	7 years 7 months 6 days
Weighted average remaining contractual term (in years) of options exercisable	2 years 6 months
Aggregate intrinsic value	$ 0.0	$ 0.0
Aggregate intrinsic value of options expected to vest	0.0
Aggregate intrinsic value of options exercisable	$ 0.0

The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.